Pharmaceutical Industry
From clinical development to real-world impact — powered by digital therapeutics.
Introduction
Pharmaceutical innovation doesn’t end with the pill — it begins with the patient. As treatments become more complex and outcomes more personalized, the need for digital companions that support adherence, education, and continuous monitoring is growing fast.
SwissDTx helps pharmaceutical companies extend the value of their therapies beyond the prescription. Through a secure and scalable digital platform, life science partners can design, deploy, and evaluate digital health interventions that complement traditional treatments, enhance engagement, and provide real-world evidence of effectiveness.
Common Challenges for Pharma Teams
Pharmaceutical organizations face increasing pressure to demonstrate value and patient-centered outcomes. Key challenges include:
- Medication adherence: Even the most effective therapies underperform if patients struggle to follow treatment plans.
- Limited real-world insights: Traditional data sources often miss behavioral, emotional, or environmental factors influencing outcomes.
- Fragmented digital landscape: Developing compliant, user-friendly apps for multiple therapeutic areas can be costly and time-consuming.
- Regulatory complexity: Navigating data privacy, medical device regulation, and post-market surveillance requirements across jurisdictions adds friction to innovation.
- Engagement beyond clinical settings: Maintaining communication and support after prescription remains an unmet need.
How SwissDTx Helps
SwissDTx empowers pharmaceutical companies to transform therapies into connected health experiences — seamlessly integrating behavioral support, data collection, and evidence generation.
With SwissDTx, pharma partners can:
- Create therapy-specific digital companions that deliver personalized exercises, psychoeducation, and adherence tools.
- Collect real-world data to complement clinical endpoints and support market access or value-based healthcare models.
- Engage patients continuously through interactive modules, reminders, and feedback loops that strengthen commitment to therapy.
- Ensure compliance and safety with a platform developed under Swiss data protection standards and aligned with MDR requirements.
- Accelerate go-to-market timelines by leveraging an existing, modular infrastructure — customizable to brand, indication, and geography.
By integrating SwissDTx into their digital health strategies, pharmaceutical partners can enhance outcomes, build trust, and stay connected with the people their innovations serve.
Interested in co-developing a digital companion or DTx solution?
